CN Patent

CN105338977A — 艾日布林和乐伐替尼作为治疗癌症的联合疗法的用途

Assigned to Sanitary Material R&d Management Co ltd · Expires 2016-02-17 · 10y expired

What this patent protects

本发明提供用于治疗与过度的细胞增殖有关的疾病，例如癌症的方法和组合物。

USPTO Abstract

本发明提供用于治疗与过度的细胞增殖有关的疾病，例如癌症的方法和组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN105338977A
Jurisdiction
CN
Classification
—
Expires
2016-02-17
Drug substance claim
No
Drug product claim
No
Assignee
Sanitary Material R&d Management Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.